Re (RMAX) Cash & Equivalents (2012 - 2026)

Re (RMAX) has reported Cash & Equivalents for 15 consecutive years, with $107.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 20.22% year-over-year to $107.1 million; the TTM figure through Mar 2026 stood at $107.1 million (up 20.22% YoY), while the FY2025 annual figure was $118.7 million, up 22.89% from the prior year.
• Cash & Equivalents slipped to $107.1 million in Q1 2026 per RMAX's latest filing, from $118.7 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $118.7 million in Q4 2025 and bottomed at $66.1 million in Q2 2024.
• Historically, Cash & Equivalents has averaged $98.5 million across 5 years, with a median of $96.8 million in 2023.
• Annual changes were most pronounced in 2024 — Cash & Equivalents tumbled 31.72% — and 2025, when it soared 42.76%.
• Re's Cash & Equivalents stood at $108.7 million in 2022, then slipped by 23.96% to $82.6 million in 2023, then grew by 16.94% to $96.6 million in 2024, then advanced by 22.89% to $118.7 million in 2025, then fell by 9.78% to $107.1 million in 2026.
• Business Quant data shows RMAX's Cash & Equivalents at $107.1 million in Q1 2026, $118.7 million in Q4 2025, and $107.5 million in Q3 2025.